Xiaobin Cui

1.9k total citations · 1 hit paper
79 papers, 1.4k citations indexed

About

Xiaobin Cui is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Xiaobin Cui has authored 79 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 23 papers in Surgery and 21 papers in Oncology. Recurrent topics in Xiaobin Cui's work include Esophageal Cancer Research and Treatment (21 papers), RNA modifications and cancer (17 papers) and Cancer-related molecular mechanisms research (13 papers). Xiaobin Cui is often cited by papers focused on Esophageal Cancer Research and Treatment (21 papers), RNA modifications and cancer (17 papers) and Cancer-related molecular mechanisms research (13 papers). Xiaobin Cui collaborates with scholars based in China, Australia and United States. Xiaobin Cui's co-authors include Yunzhao Chen, Jianming Hu, Chunxia Liu, Lan Yang, Hao Peng, Hong Zhou, Weihua Liang, Xueping Han, Jie Yu and Lan Yang and has published in prestigious journals such as PLoS ONE, Cancer Research and Gene.

In The Last Decade

Xiaobin Cui

77 papers receiving 1.4k citations

Hit Papers

Epigenetically upregulated oncoprotein PLCE1 drives esoph... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobin Cui China 20 908 518 273 219 216 79 1.4k
Jianghong Wu China 23 901 1.0× 379 0.7× 317 1.2× 193 0.9× 200 0.9× 49 1.6k
Wenting Xu China 18 872 1.0× 412 0.8× 424 1.6× 206 0.9× 162 0.8× 46 1.6k
Xujun He China 23 843 0.9× 539 1.0× 254 0.9× 176 0.8× 163 0.8× 60 1.3k
Guo‐Hui Fu China 22 801 0.9× 443 0.9× 298 1.1× 128 0.6× 137 0.6× 64 1.4k
Wenlong Zhai China 18 765 0.8× 450 0.9× 224 0.8× 162 0.7× 216 1.0× 59 1.2k
Jinbo Gao China 19 588 0.6× 292 0.6× 257 0.9× 201 0.9× 245 1.1× 66 1.1k
Junhong Zhao China 19 805 0.9× 469 0.9× 244 0.9× 120 0.5× 166 0.8× 32 1.2k
Yan Zhu China 21 518 0.6× 347 0.7× 399 1.5× 243 1.1× 205 0.9× 69 1.3k
Jing Kong China 22 807 0.9× 449 0.9× 412 1.5× 206 0.9× 226 1.0× 67 1.6k
Tsu‐Yao Cheng Taiwan 20 775 0.9× 301 0.6× 365 1.3× 237 1.1× 284 1.3× 42 1.4k

Countries citing papers authored by Xiaobin Cui

Since Specialization
Citations

This map shows the geographic impact of Xiaobin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Cui more than expected).

Fields of papers citing papers by Xiaobin Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Cui. The network helps show where Xiaobin Cui may publish in the future.

Co-authorship network of co-authors of Xiaobin Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobin Cui. A scholar is included among the top collaborators of Xiaobin Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobin Cui. Xiaobin Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xinqi, Yi Hu, Jie Yu, et al.. (2025). Incidence of MSI-H esophageal carcinoma and related identification of genomic alterations: A multi-center real-world study. Human Pathology. 163. 105878–105878.
2.
Liu, Mingxin, Yiping Jiao, Yao Liu, et al.. (2025). IBDAIM:Artificial intelligence for analyzing intestinal biopsies pathological images for assisted integrated diagnostic of inflammatory bowel disease. International Journal of Medical Informatics. 203. 106024–106024.
3.
Jiao, Yiping, Xiangxue Wang, Chunyan Peng, et al.. (2024). Pathologist-level diagnosis of ulcerative colitis inflammatory activity level using an automated histological grading method. International Journal of Medical Informatics. 192. 105648–105648. 5 indexed citations
5.
Sun, Qi, Qi Li, Fuping Gao, et al.. (2022). HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria. Journal of Cancer Research and Clinical Oncology. 149(2). 579–592. 4 indexed citations
6.
Wu, Chunlin, Ying Wang, Yan Ren, et al.. (2021). Rare Primary Pulmonary Primitive Neuroectodermal Tumor: A Case Report and Literature Review. OncoTargets and Therapy. Volume 14. 139–144. 1 indexed citations
7.
Wang, Shasha, et al.. (2019). Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma. Molecular Omics. 15(1). 88–100. 8 indexed citations
8.
Wang, Qian, Dong Liu, Kaige Wang, et al.. (2019). Hypermethylation of miR-34b/c is associated with early clinical stages and tumor differentiation in Kazakh patients with esophageal squamous cell carcinoma.. PubMed Central. 12(8). 3119–3127. 3 indexed citations
9.
Chen, Yunzhao, Dandan Wang, Hao Peng, et al.. (2019). Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression. Molecular Cancer. 18(1). 1–1. 306 indexed citations breakdown →
10.
Yang, Jiancheng, Jingbao Li, Xiaobin Cui, et al.. (2019). Blocking glucocorticoid signaling in osteoblasts and osteocytes prevents mechanical unloading-induced cortical bone loss. Bone. 130. 115108–115108. 31 indexed citations
11.
Li, Yong, Ping Gong, Wei Huang, et al.. (2018). miR-34a Regulates Multidrug Resistance via Positively Modulating OAZ2 Signaling in Colon Cancer Cells. Journal of Immunology Research. 2018. 1–13. 29 indexed citations
13.
Wu, Fei, Mei Li, Weiyan You, et al.. (2017). A Genetic Variant in miR-124 Decreased the Susceptibility to Esophageal Squamous Cell Carcinoma in a Chinese Kazakh Population. Genetic Testing and Molecular Biomarkers. 22(1). 29–34. 9 indexed citations
15.
Xie, Yuwen, Weiwei Wang, Dong Liu, et al.. (2015). Hypermethylation of potential tumor suppressor miR-34b/c is correlated with late clinical stage in patients with soft tissue sarcomas. Experimental and Molecular Pathology. 98(3). 446–454. 11 indexed citations
16.
Yang, Lan, Ling Chen, Tingting Li, et al.. (2015). Heterozygote of TAP1 Codon637 decreases susceptibility to HPV infection but increases susceptibility to esophageal cancer among the Kazakh populations. Journal of Experimental & Clinical Cancer Research. 34(1). 70–70. 19 indexed citations
17.
Cao, Yuwen, Shiying Yu, Xiaobin Cui, et al.. (2014). BRCA1 Gene Exon 11 Mutations in Uighur and Han Women with Early-onset Sporadic Breast Cancer in the Northwest Region of China. Asian Pacific Journal of Cancer Prevention. 15(11). 4513–4518. 6 indexed citations
18.
Cao, Yuwen, et al.. (2014). Implications of the Notch1‐Snail/Slug‐epithelial to mesenchymal transition axis for lymph node metastasis in infiltrating ductal carcinoma. The Kaohsiung Journal of Medical Sciences. 31(2). 70–76. 27 indexed citations
19.
Hu, Junwen M., Ling Li, Yun Zhao Chen, et al.. (2014). HLA-DRB1andHLA-DQB1methylation changes promote the occurrence and progression of Kazakh ESCC. Epigenetics. 9(10). 1366–1373. 16 indexed citations
20.
Cui, Xiaobin, Yunzhao Chen, Xuelian Pang, et al.. (2013). Multiple polymorphisms within the PLCE1 are associated with esophageal cancer via promoting the gene expression in a Chinese Kazakh population. Gene. 530(2). 315–322. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026